Stoicovy RA, International Journal of Molecular Sciences (Vol
The Lancet, 2026 Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet What happens if we control the diet after as well thats what I wonder, like no UPFs whole food and plenty of fibre - these drugs are literally miracle workers but if we cant reeducate and change peoples relationship with food, including access to whole foods and plenty of fibre, is it that surprising a finding
Fat mass reduction The body composition substudy measured total fat mass changes using dual-energy X-ray absorptiometry, the gold standard for distinguishing fat from lean tissue
KEY OBSERVATIONS Live chat is primarily an AI bot, available only to active patients
The general results between semaglutide and tirzepatide are very close